In the featured translational article in the August issue of The Journal of Nuclear Medicine, researchers at the University of Michigan demonstrate the potential of a new PET tracer, Carbon-11 labeled sarcosine (11C-sarcosine), for imaging prostate cancer, and set the stage for its possible use in monitoring other cancers.
A Massachusetts General Hospital study has found that deficits in the sense of smell are important contributors to the frequently observed lack of appetite in patients with serious kidney disease.
New research offers a possible explanation for why a new type of cancer treatment hasn't been working as expected against bladder cancer.
Scientists have devised a simple test for an earlier and more accurate warning of returning bladder cancer than existing methods, according to research published in the British Journal of Cancer today.
Researchers from the University of Liverpool with colleagues from Gynuity Health Care in New York and the Government Medial College, Nagpur, India, have published a major study of two different types of labour induction methods in The Lancet.
Treatment of benign prostatic hyperplasia (BPH) with the commonly prescribed Avodart (Dutsteride) may put men at an increased risk for diabetes, elevated cholesterol levels, non-alcoholic fatty liver disease (NAFLD) and worsening erectile dysfunction.
Paracetamol during pregnancy can inhibit masculinity Paracetamol during pregnancy can inhibit the development of 'male behavior' in mice. New research from the University of Copenhagen shows that it can reduce sex drive and aggressive behavior.
In couples who have not been able to have children, male infertility is the cause in at least half of cases. In 6-10% the cause is a urogenital infection. The risk of irreversible infertility associated with urogenital infections in men should not be underestimated, say Hans-Christian Schuppe and coauthors in a review article in the current issue of Deutsches Ärzteblatt International (Dtsch Arztebl Int 2017; 114: 321-7).
A new study that includes data from four Australian medical centers shows that Ga-68 Prostate Specific Membrane Antigen (PSMA) PET/CT detects prostate cancer not caught by more conventional imaging, thus affecting treatment plans. The research was presented at the 2017 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI).
A new, minimally invasive system which uses radiofrequency energy instead of open surgery to create access for patients needing hemodialysis is reliable, with minimal complications, according to data published in the American Journal of Kidney Disease.